Skip to content
Disclosery

ORACLE INVESTMENT MANAGEMENT INC

Follow

13F filer, CIK 1012622, GREENWICH, CT

ORACLE INVESTMENT MANAGEMENT INC reported $107,191,036 across 22 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-14. Its ten largest share positions make up 96.48% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-24-004012

Period
2024-06-30
Reported value
$107M
Holdings
22
Top 10 weight
96.48%
New
4
Sold out
9

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PHATnew+225,000$2.32M
MYGNnew+60,000$1.47M
AGENnew+17,500$293K
CAVAadded+1,000$92.8K
FORAadded+300$795

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPRINGWORKS THERAPEUTICS INCreduced-188,383-$7.1M
ARDXreduced-551,569-$4.09M
BHVNreduced-104,400-$3.62M
EYPTreduced-230,000-$2M
IMMPexited-564,879-$1.32M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0001085146-24-004012, largest first. % of portfolio is the value over $93,198,384, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,126,607 shares; 2024Q2: 1,105,768 shares 1,105,768$28.9M31.01%-20,839Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 804,850 shares; 2024Q2: 700,450 shares 700,450$24.3M26.09%-104,400Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,039,700 shares; 2024Q2: 1,488,131 shares 1,488,131$11M11.83%-551,569Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 421,583 shares; 2024Q2: 233,200 shares 233,200$8.78M9.43%-188,383
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 157,201 shares; 2024Q2: 118,291 shares 118,291$3.93M4.22%-38,910Timeline
FORAFORIAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,355,807 shares; 2024Q2: 1,356,107 shares 1,356,107$3.59M3.86%+300Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 535,558 shares; 2024Q2: 535,558 shares 535,558$3.31M3.55%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 225,000 shares 225,000$2.32M2.49%newTimeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 461,857 shares; 2024Q2: 231,857 shares 231,857$2.02M2.16%-230,000Timeline
CAVACAVA GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 17,600 shares; 2024Q2: 18,600 shares 18,600$1.73M1.85%+1,000Timeline
MYGNMYRIAD GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 60,000 shares 60,000$1.47M1.57%newTimeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,356,026 shares; 2024Q2: 423,138 shares 423,138$580K0.62%-932,888Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,412 shares; 2024Q2: 2,412 shares 2,412$559K0.6%0Timeline
WALGREENS BOOTS ALLIANCE INCWALGREENS BOOTS ALLIANCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 27,500 shares; 2024Q2: 27,500 shares 27,500$333K0.36%0
AGENAGENUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 17,500 shares 17,500$293K0.31%newTimeline
BIODESIX INCBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 30,351 shares; 2024Q2: 28,916 shares 28,916$44.2K0.05%-1,435

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
BIOHAVEN LTDBIOHAVEN LTD COMcall115,000$3.99M-4,500
EYEPOINT INCEYEPOINT INC CALLcall438,100$3.81M+409,500
ARDELYX INCARDELYX INC COMcall259,600$1.92M-11,300
MYRIAD GENETICS INCMYRIAD GENETICS INC COMcall74,500$1.82Mnew
PALANTIR TECHNOLOGIES INCPALANTIR TECHNOLOGIES INC CALLcall70,000$1.77M+45,000
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC CALLcall17,800$671K-25,100

Sold out in Q2 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
WALGREENS BOOTS ALLIANCE INCWALGREENS BOOTS ALLIANCE INC410,000$8.89Mcall
XBISPDR SERIES TRUST35,000$3.32Mcall
STAAR SURGICAL COSTAAR SURGICAL CO35,000$1.34Mcall
IMMPIMMUTEP LTD564,879$1.32Mshares
PACIFIC BIOSCIENCES CALIF INPACIFIC BIOSCIENCES CALIF IN250,000$938Kcall
AGENUS INCAGENUS INC1,066,963$619Kshares
OPTINOSE INCOPTINOSE INC325,000$474Kshares
AXDXQACCELERATE DIAGNOSTICS INC42,101$41.7Kshares
DERMTECH INCDERMTECH INC47,687$33.5Kshares

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-24-004012 base2024-08-14acceptance time not in the bulk data set